Skip to content
Sunday, November 8, 2026
Discover premium lifestyle insights, luxury travel guides, …

Zimbabwe Turns Down ‘Lopsided’ American Healthcare Assistance Deal Over Data Fears

Medical funding image
The proposed American funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) over five years because of Washington's request for sensitive biological samples.

The decision became public following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".

A government spokesman has since clarified that the US was requesting genetic material for scientific study and commercial purposes but refused to guarantee the benefits from any future vaccines.

"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for further negotiations to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.

Broader Implications

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' health data.

After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.

The agency had overseen aid for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.

As per reports, 16 African countries have to date agreed to these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to share its genetic material and health information indefinitely, with no corresponding promise of access to any medical innovations – like new medicines or tests – that could result from that provided information," he stated.

"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our citizens should a future pandemic emerge."

National Interest and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures previously established via the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This framework is intended to guarantee that when a country provides its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."

These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our American counterparts on how future co-operation might be structured in a way that honours the sovereignty and dignity of each country."

Medical Community Response

A leading public health body said it recognised the official position, but urged that talks should continue considering a large portion of the country's Aids initiatives depended on external financing.

"If technical issues arise, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.

This impasse highlights the continuing challenges between receiving vital foreign assistance and protecting a country's data in an ever more data-driven world.

DM
The writer

Danielle Mercer

A seasoned luxury lifestyle journalist and travel expert with over a decade of experience covering high-end destinations and exclusive events worldwide.

Stellar VIP Online

Type to search articles.